Telix Pharmaceuticals Limited Stock Buy Hold or Sell Recommendation

TLX Stock   15.76  0.16  1.03%   
Considering the 90-day investment horizon and your way above-average risk tolerance, our recommendation regarding Telix Pharmaceuticals Limited is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Telix Pharmaceuticals Limited given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Telix Pharmaceuticals Limited, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Telix Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Telix and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Telix Pharmaceuticals Buy or Sell Advice

The Telix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Telix Pharmaceuticals Limited. Macroaxis does not own or have any residual interests in Telix Pharmaceuticals Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Telix Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Telix PharmaceuticalsBuy Telix Pharmaceuticals
Hold

Market Performance

ModestDetails

Volatility

Not too volatileDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Telix Pharmaceuticals Limited has a Risk Adjusted Performance of 0.0692, Jensen Alpha of 0.1717, Total Risk Alpha of (0.10), Sortino Ratio of 0.0548 and Treynor Ratio of 0.7075
Our advice tool can cross-verify current analyst consensus on Telix Pharmaceuticals and to analyze the firm potential to grow in the current economic cycle. To make sure Telix Pharmaceuticals is not overpriced, please validate all Telix Pharmaceuticals fundamentals, including its number of shares shorted, total debt, as well as the relationship between the Total Debt and market capitalization . Given that Telix Pharmaceuticals has a shares outstanding of 334.72 M, we advise you to double-check Telix Pharmaceuticals Limited market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Telix Pharmaceuticals Trading Alerts and Improvement Suggestions

Telix Pharmaceuticals Returns Distribution Density

The distribution of Telix Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Telix Pharmaceuticals' future price movements. The chart of the probability distribution of Telix Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Telix Pharmaceuticals Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Telix Pharmaceuticals returns is essential to provide solid investment advice for Telix Pharmaceuticals.
Mean Return
0.21
Value At Risk
-2.14
Potential Upside
4.38
Standard Deviation
2.41
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Telix Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Telix Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Telix Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Telix Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Telix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.17
β
Beta against Dow Jones0.28
σ
Overall volatility
2.41
Ir
Information ratio 0.04

Telix Pharmaceuticals Volatility Alert

Telix Pharmaceuticals Limited has relatively low volatility with skewness of 1.2 and kurtosis of 1.69. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Telix Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Telix Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Telix Pharmaceuticals Fundamentals Vs Peers

Comparing Telix Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Telix Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Telix Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Telix Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Telix Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Telix Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Telix Pharmaceuticals to competition
FundamentalsTelix PharmaceuticalsPeer Average
Return On Equity0.2-0.31
Return On Asset0.0797-0.14
Profit Margin0.08 %(1.27) %
Operating Margin0.09 %(5.51) %
Current Valuation5.17 B16.62 B
Shares Outstanding334.72 M571.82 M
Number Of Shares Shorted8.78 K4.71 M
Price To Book20.50 X9.51 X
Price To Sales8.17 X11.42 X
Revenue496.66 M9.43 B
EBITDA22.97 M3.9 B
Net Income5.21 M570.98 M
Total Debt17.45 M5.32 B
Book Value Per Share1.21 X1.93 K
Short Ratio0.16 X4.00 X
Earnings Per Share0.09 X3.12 X
Target Price20.69
Beta2.38-0.15
Market Capitalization5.28 B19.03 B
Total Asset398.3 M29.47 B
Retained Earnings(263.67 M)9.33 B
Working Capital67.44 M1.48 B
Net Asset398.3 M

Telix Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Telix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Telix Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Telix Pharmaceuticals Limited? Buying financial instruments such as Telix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Telix Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rubber and Plastic Products Thematic Idea Now

Rubber and Plastic Products
Rubber and Plastic Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.